Table of Contents Author Guidelines Submit a Manuscript
Neurology Research International
Volume 2011 (2011), Article ID 759895, 6 pages
http://dx.doi.org/10.1155/2011/759895
Review Article

Dopamine Dysregulation Syndrome and Deep Brain Stimulation of the Subthalamic Nucleus in Parkinson's Disease

1Movement Disorders Research Unit, Hospital Universitario Gregorio Marañón, 28007 Madrid, Spain
2Servicio de Neurología, Hospital General Universitario Gregorio Marañón, C/Doctor Esquerdo 46, 28007 Madrid, Spain

Received 9 March 2011; Revised 9 September 2011; Accepted 15 September 2011

Academic Editor: B. R. Ott

Copyright © 2011 Beatriz De la Casa-Fages and Francisco Grandas. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. G. Giovannoni, J. D. O'Sullivan, K. Turner, A. J. Manson, and A. J. L. Lees, “Hedonistic homeostatic dysregulation in patients with Parkinson's disease on dopamine replacement therapies,” Journal of Neurology Neurosurgery and Psychiatry, vol. 68, no. 4, pp. 423–428, 2000. View at Publisher · View at Google Scholar · View at Scopus
  2. A. H. Evans, A. P. Strafella, D. Weintraub, and M. Stacy, “Impulsive and compulsive behaviors in Parkinson's disease,” Movement Disorders, vol. 24, no. 11, pp. 1561–1570, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  3. F. R. Pezzella, C. Colosimo, N. Vanacore et al., “Prevalence and clinical features of hedonistic homeostatic dysregulation in Parkinson's disease,” Movement Disorders, vol. 20, no. 1, pp. 77–81, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  4. S. S. O'Sullivan, A. H. Evans, and A. J. Lees, “Dopamine dysregulation syndrome: an overview of its epidemiology, mechanisms and management,” CNS Drugs, vol. 23, no. 2, pp. 157–170, 2009. View at Publisher · View at Google Scholar · View at Scopus
  5. A. H. Evans, A. D. Lawrence, J. Potts, S. Appel, and A. J. Lees, “Factors influencing susceptibility to compulsive dopaminergic drug use in Parkinson's disease,” Neurology, vol. 65, no. 10, pp. 1570–1574, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  6. R. Katzenschlager, “Dopaminergic dysregulation syndrome in Parkinson's disease,” Journal of the Neurological Sciences, vol. 310, no. 1-2, pp. 271–275, 2011. View at Publisher · View at Google Scholar · View at PubMed
  7. A. D. Lawrence, A. H. Evans, and A. J. Lees, “Compulsive use of dopamine replacement therapy in Parkinson's disease: reward systems gone awry?” The Lancet Neurology, vol. 2, no. 10, pp. 595–604, 2003. View at Publisher · View at Google Scholar · View at Scopus
  8. P. Schwingenschuh, P. Katschnig, R. Saurugg, E. Ott, and K. P. Bhatia, “Artistic profession: a potential risk factor for dopamine dysregulation syndrome in Parkinson's disease?” Movement Disorders, vol. 25, no. 4, pp. 493–496, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  9. E. M. Sammler, R. J. Swingler, A. Stuart, and M. Muqit, “Dopamine dysregulation syndrome in a patient with early onset Parkinsonism and Parkin gene mutations,” Movement Disorders, vol. 24, no. 16, pp. 2442–2443, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  10. C. Scherfler, N. L. Khan, N. Pavese et al., “Upregulation of dopamine D2 receptors in dopaminergic drug-naive patients with Parkin gene mutations,” Movement Disorders, vol. 21, no. 6, pp. 783–788, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  11. A. H. Evans, N. Pavese, A. D. Lawrence et al., “Compulsive drug use linked to sensitized ventral striatal dopamine transmission,” Annals of Neurology, vol. 59, no. 5, pp. 852–858, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  12. T. D. Steeves, J. Miyasaki, M. Zurowski et al., “Increased striatal dopamine release in Parkinsonian patients with pathological gambling: a [11C] raclopride PET study,” Brain, vol. 132, no. 5, pp. 1376–1385, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  13. F. M. Weaver, K. Follett, M. Stern et al., “Bilateral deep brain stimulation vs best medical therapy for patients with advanced parkinson disease: a randomized controlled trial,” Journal of the American Medical Association, vol. 301, no. 1, pp. 63–73, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  14. J. L. Houeto, V. Mesnage, L. Mallet et al., “Behavioral disorders, Parkinson's disease and subthalamic stimulation,” Journal of Neurology, Neurosurgery and Psychiatry, vol. 72, no. 6, pp. 701–707, 2002. View at Publisher · View at Google Scholar
  15. K. A. Follett, F. M. Weaver, M. Stern et al., “Pallidal versus subthalamic deep-brain stimulation for Parkinson's disease,” New England Journal of Medicine, vol. 362, no. 22, pp. 2077–2091, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  16. T. Witjas, C. Baunez, J. M. Henry et al., “Addiction in Parkinson's disease: impact of subthalamic nucleus deep brain stimulation,” Movement Disorders, vol. 20, no. 8, pp. 1052–1055, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  17. D. Knobel, S. Aybek, C. Pollo, F. J. G. Vingerhoets, and A. Berney, “Rapid resolution of dopamine dysregulation syndrome (DDS) after subthalamic DBS for parkinson disease (PD),” Cognitive and Behavioral Neurology, vol. 21, no. 3, pp. 187–189, 2008. View at Publisher · View at Google Scholar · View at PubMed
  18. F. Bandini, A. Primavera, M. Pizzorno, and L. Cocito, “Using STN DBS and medication reduction as a strategy to treat pathological gambling in Parkinson's disease,” Parkinsonism and Related Disorders, vol. 13, no. 6, pp. 369–371, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  19. S. Y. Lim, S. S. O'Sullivan, K. Kotschet et al., “Dopamine dysregulation syndrome, impulse control disorders and punding after deep brain stimulation surgery for Parkinson's disease,” Journal of Clinical Neuroscience, vol. 16, no. 9, pp. 1148–1152, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  20. W. M. Schüpbach, N. Chastan, M. L. Welter et al., “Stimulation of the subthalamic nucleus in Parkinson's disease: a 5 year follow up,” Journal of Neurology, Neurosurgery and Psychiatry, vol. 76, no. 12, pp. 1640–1644, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  21. B. de la Casa-Fages and F. Grandas, “Dopamine dysregulation syndrome after deep brain stimulation of the subthalamic nucleus in Parkinson's disease,” Journal of the Neurological Sciences. In press.
  22. S. Thobois, C. Ardouin, E. Lhommée et al., “Non-motor dopamine withdrawal syndrome after surgery for Parkinson's disease: predictors and underlying mesolimbic denervation,” Brain, vol. 133, no. 4, pp. 1111–1127, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  23. E. E. Benarroch, “Subthalamic nucleus and its connections: anatomic substrate for the network effects of deep brain stimulation,” Neurology, vol. 70, no. 21, pp. 1991–1995, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  24. G. E. Alexander and M. D. Crutcher, “Functional architecture of basal ganglia circuits: neural substrates of parallel processing,” Trends in Neurosciences, vol. 13, no. 7, pp. 266–271, 1990. View at Google Scholar · View at Scopus
  25. M. Anneke, M. Frankemolle, J. Wu et al., “Reversing cognitive-motor impairments in Parkinson's disease patients using a computational modelling approach to deep brain stimulation programming,” Brain, vol. 133, no. 3, pp. 746–761, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  26. A. Mikos, D. Bowers, A. M. Noecker et al., “Patient-specific analysis of the relationship between the volume of tissue activated during DBS and verbal fluency,” NeuroImage, vol. 54, supplement 1, pp. S238–S246, 2011. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  27. F. Le Jeune, J. Péron, D. Grandjean et al., “Subthalamic nucleus stimulation affects limbic and associative circuits: a PET study,” European Journal of Nuclear Medicine and Molecular Imaging, vol. 37, no. 8, pp. 1512–1520, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  28. P. Limousin, J. Greene, P. Pollak, J. Rothwell, A. L. Benabid, and R. Frackowiak, “Changes in cerebral activity pattern due to subthalamic nucleus or internal pallidum stimulation in Parkinson's disease,” Annals of Neurology, vol. 42, no. 3, pp. 283–291, 1997. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  29. T. D. Hälbig, W. Tse, P. G. Frisina et al., “Subthalamic deep brain stimulation and impulse control in Parkinson's disease,” European Journal of Neurology, vol. 16, no. 4, pp. 493–497, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  30. H. M. Smeding, A. E. Goudriaan, E. M. Foncke, P. R. Schuurman, J. D. Speelman, and B. Schmand, “Pathological gambling after bilateral subthalamic nucleus stimulation in Parkinson disease,” Journal of Neurology, Neurosurgery and Psychiatry, vol. 78, no. 5, pp. 517–519, 2007. View at Publisher · View at Google Scholar · View at PubMed
  31. B. Ballanger, T. van Eimeren, E. Moro et al., “Stimulation of the subthalamic nucleus and impulsivity: release your horses,” Annals of Neurology, vol. 66, no. 6, pp. 817–824, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  32. F. Le Jeune, D. Drapier, A. Bourguignon et al., “Subthalamic nucleus stimulation in Parkinson disease induces apathy: a PET study,” Neurology, vol. 73, no. 21, pp. 1746–1751, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  33. A. Funkiewiez, C. Ardouin, P. Krack et al., “Acute psychotropic effects of bilateral subthalamic nucleus stimulation and levodopa in Parkinson's disease,” Movement Disorders, vol. 18, no. 5, pp. 524–530, 2003. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  34. J. C. Morgan, C. J. diDonato, S. S. Iyer, P. D. Jenkins, J. R. Smith, and K. D. Sethi, “Self-stimulatory behavior associated with deep brain stimulation in Parkinson's disease,” Movement Disorders, vol. 21, no. 2, pp. 283–285, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  35. M. C. Rodriguez-Oroz, M. Jahanshahi, P. Krack et al., “Initial clinical manifestations of Parkinson's disease: features and pathophysiological mechanisms,” The Lancet Neurology, vol. 8, no. 12, pp. 1128–1139, 2009. View at Publisher · View at Google Scholar · View at Scopus
  36. F. Ambroggi, A. Ishikawa, H. L. Fields, and S. M. Nicola, “Basolateral amygdala neurons facilitate reward-seeking behavior by exciting nucleus accumbens neurons,” Neuron, vol. 59, no. 4, pp. 648–661, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  37. A. H. Evans, A. D. Lawrence, S. A. Cresswell, R. Katzenschlager, and A. J. Lees, “Compulsive use of dopaminergic drug therapy in Parkinson's disease: reward and anti-reward,” Movement Disorders, vol. 25, no. 7, pp. 867–876, 2010. View at Publisher · View at Google Scholar · View at PubMed
  38. D. Weintraub, S. Hoops, J. A. Shea et al., “Validation of the questionnaire for impulsive-compulsive disorders in Parkinson's disease,” Movement Disorders, vol. 24, no. 10, pp. 1461–1467, 2009. View at Publisher · View at Google Scholar · View at PubMed